Terms: = Germ cell tumor AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
106 results:
1. [Fully Automatic Glioma Segmentation Algorithm of Magnetic Resonance Imaging Based on 3D-UNet With More Global Contextual Feature Extraction: An Improvement on Insufficient Extraction of Global Features].
Tian H; Wang Y; Ji Y; Rahman MM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):447-454. PubMed ID: 38645864
[TBL] [Abstract] [Full Text] [Related]
2. The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.
Clement DSVM; van Leerdam ME; Tesselaar MET; Cananea E; Martin W; Weickert MO; Sarker D; Ramage JK; Srirajaskanthan R
J Neuroendocrinol; 2024 Apr; 36(4):e13376. PubMed ID: 38389192
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract] [Full Text] [Related]
4. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
5. Lost in translation: evaluating the readability of online patient information for neuroendocrine tumors.
Paschke A; Grewal US
Endocrine; 2024 Apr; 84(1):97-99. PubMed ID: 38010471
[TBL] [Abstract] [Full Text] [Related]
6. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients.
Morini M; Raggi F; Bartolucci M; Petretto A; Ardito M; Rossi C; Segalerba D; Garaventa A; Eva A; Cangelosi D; Bosco MC
Cells; 2023 Oct; 12(21):. PubMed ID: 37947594
[TBL] [Abstract] [Full Text] [Related]
7. Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma.
Li M; Liao K; Nowakowska M; Wehner M; Shih YT
J Manag Care Spec Pharm; 2023 Nov; 29(11):1232-1241. PubMed ID: 37889870
[No Abstract] [Full Text] [Related]
8. Nomograms Based on MRI Radiomics for Differential diagnosis and Predicting BRAFV600E Expression in Pleomorphic Xanthoastrocytoma and Ganglioglioma.
Kong X; Mao Y; Xi F; Li Y; Luo Y; Ma J
Acad Radiol; 2024 Mar; 31(3):1069-1081. PubMed ID: 37741731
[TBL] [Abstract] [Full Text] [Related]
9. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Georgakopoulos A
Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
[TBL] [Abstract] [Full Text] [Related]
10. Small Bowel Neuroendocrine tumors-10-Year Experience of the Ottawa Hospital (TOH).
Alfagih A; AlJassim A; Alqahtani N; Vickers M; Goodwin R; Asmis T
Curr Oncol; 2023 Aug; 30(8):7508-7519. PubMed ID: 37623025
[TBL] [Abstract] [Full Text] [Related]
11. Health care resource use and costs among patients with carcinoid syndrome in France: Analysis of the National Health Insurance Database.
Perrier M; Mouawad C; Gueguen D; Thomé B; Lapeyre-Mestre M; Walter T
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102177. PubMed ID: 37453678
[TBL] [Abstract] [Full Text] [Related]
12. Enhancing information on stage at diagnosis for childhood cancer in Africa.
Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
[TBL] [Abstract] [Full Text] [Related]
13. Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium.
Schraw JM; Petridou ET; Bonaventure A; Dockerty JD; Karalexi M; Ntzani E; Infante-Rivard C; Clavel J; Bracci PM; McKean-Cowdin R; Roman E; Kane E; Erdmann F; Schüz J; Mueller BA; Scheurer ME
Cancer Causes Control; 2023 Nov; 34(11):1005-1015. PubMed ID: 37421504
[TBL] [Abstract] [Full Text] [Related]
14. The Impact of Social Determinants of Health on Vestibular Schwannoma Management: A Single Institution Review.
Ellsperman SE; Bellile E; Fryatt R; Hoi K; Wang J; Fayson S; Banakis Hartl RM; Stucken EZ
Otol Neurotol; 2023 Jun; 44(5):507-512. PubMed ID: 37167450
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
de Godoy LL; Chawla S; Brem S; Wang S; O'Rourke DM; Nasrallah MP; Desai A; Loevner LA; Liau LM; Mohan S
J Neurooncol; 2023 May; 163(1):173-183. PubMed ID: 37129737
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of [
Chen D; Yang S; Chen J; Li T; Liu Y; Zhao X; Zhang T; Xu M; Wang H; Zhao K; Su X
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2420-2431. PubMed ID: 36971805
[TBL] [Abstract] [Full Text] [Related]
17. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
[TBL] [Abstract] [Full Text] [Related]
18. Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls.
Guaragna-Filho G; Guerra-Junior G; Tadokoro-Cuccaro R; Hughes IA; Barros BA; Hiort O; Balsamo A; Guran T; Holterhus PM; Hannema S; Poyrazoglu S; Darendeliler F; Bryce J; Ahmed SF; Quigley CA
Sex Dev; 2023; 17(1):16-25. PubMed ID: 36917969
[TBL] [Abstract] [Full Text] [Related]
19. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
[TBL] [Abstract] [Full Text] [Related]
20. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Stiefel R; Lehmann K; Winder T; Siebenhüner AR
BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
[TBL] [Abstract] [Full Text] [Related]
[Next]
